Vonoprazan fumarate

From WikiMD.org
Jump to navigation Jump to search

Vonoprazan Fumarate

Vonoprazan Fumarate (pronunciation: voh-noh-pra-zan fyoo-muh-rate) is a potassium-competitive acid blocker (P-CAB) that is used in the treatment of acid-related diseases. It is a novel type of proton pump inhibitor (PPI) that has shown to be more effective than traditional PPIs in some studies.

Etymology

The name "Vonoprazan" is derived from the chemical structure of the drug. "Vono" is a prefix used in the naming of some pharmaceuticals, and "prazan" is a suffix often used for drugs that affect the gastrointestinal tract. The term "fumarate" refers to the salt or ester form of fumaric acid, which is used in the formulation of the drug.

Usage

Vonoprazan Fumarate is used in the treatment of various acid-related diseases, including gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and Helicobacter pylori infection. It works by blocking the final step of gastric acid secretion in the stomach, thereby reducing the amount of acid produced.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski